Patient info Open main menu

Eurican Herpes 205 - Patient leaflet, side effects, dosage

Contains active substance :

Dostupné balení:

Patient leaflet - Eurican Herpes 205

B. PACKAGE LEAFLET

PACKAGE LEAFLET:

Eurican Herpes 205 powder and solvent for emulsion for injection

  • 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

Marketing authorisation holder :

Boehringer Ingelheim Vetmedica GmbH

55216 Ingelhe­im/Rhein

GERMANY

Manufacturer responsible for batch release :

Boehringer Ingelheim Animal Health France SCS

Laboratoire Porte des Alpes

Rue de l’Aviation

69800 Saint Priest

FRANCE

  • 2. NAME OF THE VETERINARY MEDICINAL PRODUCT

Eurican Herpes 205 powder and solvent for emulsion for injection

  • 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)

Per 1 ml dose:

Lyophilisate :

Active substance:

0.3 to 1.75 ^g*


224.8 to 244.1 mg


Canine herpesvirus (F205 strain) antigens

*expressed in ^g of gB glycoproteins

Solvent:

Adjuvant : Light paraffin oil

Lyophilisate: white pellet.

Solvent: homogeneous white emulsion

4.


INDICATIONS


Active immunisation of pregnant bitches to prevent mortality, clinical signs and lesions in puppies resulting from canine herpes virus infections acquired in the first few days of life through passive immunity.

  • 5. CONTRAINDI­CATIONS

None.

  • 6. ADVERSE REACTIONS

The vaccine may commonly cause transient oedema at the site of injection. These reactions usually regress within one week.

Hypersensitivity reactions may rarely occur. Appropriate symptomatic treatment should be administered.

The frequency of adverse reactions is defined using the following convention:

  • – very common (more than 1 in 10 animals treated displaying adverse reaction(s))

  • – common (more than 1 but less than 10 animals in 100 animals treated)

  • – uncommon (more than 1 but less than 10 animals in 1,000 animals treated)

  • – rare (more than 1 but less than 10 animals in 10,000 animals treated)

  • – very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

If you notice any serious effects or other effects, even those not already listed in this package leaflet, or you think that the medicine has not worked, please inform your veterinary surgeon.

  • 7. TARGET SPECIES

Dogs.

  • 8. DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION

Following reconstitution of the powder with the solvent, inject one dose (1 ml) of the vaccine via the subcutaneous route, according to the following schedule:

First injection :

Second injection : Revaccination :


Either during heat or 7 to 10 days after the presumed date of mating. 1 to 2 weeks before the expected date of whelping.

During each pregnancy, according to the same schedule.

  • 9. ADVICE ON CORRECT ADMINISTRATION

Aseptically reconstitute the contents of the powder with the solvent supplied with this vaccine. The reconstituted content shall be a milky emulsion.

10.


WITHDRAWAL PERIOD(S)


Not applicable.

  • 11. SPECIAL STORAGE PRECAUTIONS

Keep out of the sight and reach of children

Store in a refrigerator (2 °C – 8 °C).

Do not freeze.

Protect from light.

Shelf life after reconstitution according to directions: use immediately.

Do not use this veterinary medicinal product after the expiry date which is stated on the label after “EXP”.

  • 12. SPECIAL WARNING(S)

Special warnings for each target species:

Vaccinate healthy animals only.

Abortion and premature parturition can occur as a result of CHV infection in bitches, the protection of the bitch against infection has not been studied for this vaccine. In order for immunity to be conferred to the puppies, sufficient intake of colostrum is required

Special precautions for use in animals:

None.

Special precautions to be taken by the person administrating the veterinary medicinal product to animals :

To the user:

This product contains mineral oil. Accidental injection/self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.

If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package insert with you.

If pain persists for more than 12 hours after medical examination, seek medical advice again.

To the physician:

This product contains mineral oil. Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.

Pregnancy and lactation:

This vaccine is specifically indicated during pregnancy.

Interaction (with other medicinal products and other forms of interaction)

No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product.

A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case-basis.

Overdose (symptoms, emergency procedures, antidotes):

No adverse effects other than those-listed in section “Adverse reactions” have been observed after the administration of several doses.

Incompatibili­ties:

Do not mix with any other veterinary medicinal product except the solvent supplied for use with the veterinary medicinal product.

  • 13. SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY

Medicines should not be disposed of via wastewater or household waste. These measures should help to protect the environment.

  • 14. DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED

Frequently Asked Questions

What is Eurican Herpes 205 used for?

Eurican Herpes 205 is a vaccine designed to protect dogs against certain strains of the herpes virus. It helps prevent the spread of the virus in canine populations.

How is Eurican Herpes 205 administered?

Eurican Herpes 205 is typically administered as an injection by a veterinarian. It may require multiple doses depending on your dog's vaccination schedule.

Is Eurican Herpes 205 safe for all dogs?

While Eurican Herpes 205 is safe for most healthy dogs, it is important to consult your veterinarian to determine if it is suitable for your pet, especially if they have underlying health conditions.

Can Eurican Herpes 205 be given to puppies?

Yes, Eurican Herpes 205 can be administered to puppies, usually starting at a specific age as recommended by your veterinarian.

What are the possible side effects of Eurican Herpes 205?

Common side effects may include mild swelling at the injection site, lethargy, or decreased appetite. Serious side effects are rare but should be reported to your veterinarian immediately.

How often should my dog receive Eurican Herpes 205 vaccination?

The vaccination schedule for Eurican Herpes 205 will depend on your dog’s age and health status. Follow your veterinarian's recommendations for boosters and re-vaccination.

Can I give my dog other vaccines on the same day as Eurican Herpes 205?

Consult with your veterinarian about administering multiple vaccines on the same day. They can provide guidance based on your dog's health and vaccination history.

What should I do if my dog has an allergic reaction to Eurican Herpes 205?

If you notice signs of an allergic reaction such as difficulty breathing, swelling of the face, or severe vomiting, contact your veterinarian or emergency veterinary services immediately.

How effective is the Eurican Herpes 205 vaccine?

Eurican Herpes 205 has shown effectiveness in preventing herpes virus infections in vaccinated populations when used according to the recommended schedule.

Are there any contraindications for using Eurican Herpes 205?

Dogs that are seriously ill, pregnant, or have known allergies to components of the vaccine may not be suitable candidates for Eurican Herpes 205. Always consult with your vet first.

Can I handle my dog differently after they receive the vaccine?

After vaccination with Eurican Herpes 205, it’s generally safe to handle your dog as usual. However, monitor them closely for any unusual reactions in the days following vaccination.

What should I do if I miss a scheduled dose of Eurican Herpes 205?

If you miss a dose, contact your veterinarian as soon as possible. They will guide you on how to proceed with rescheduling the vaccination.

Does Eurican Herpes 205 provide lifetime immunity?

Eurican Herpes 205 does not provide lifetime immunity. Regular booster shots may be needed depending on your dog's risk and exposure level.

Can older dogs receive the Eurican Herpes 205 vaccine?

Yes, older dogs can receive the vaccine. Discuss with your veterinarian about their health status and any potential risks before proceeding.

Is there any special care required after my dog receives the vaccine?

After vaccination with Eurican Herpes 205, it's best to keep an eye on your dog for any unusual behavior or side effects for at least a few hours.

How does Eurican Herpes 205 compare to other canine vaccines?

Eurican Herpes 205 specifically targets herpes viruses that affect dogs. It's vital to discuss with your vet how this fits into your dog's overall vaccination plan compared to other vaccines.

Will my dog still need regular check-ups after receiving this vaccine?

Yes, regular veterinary check-ups are important even after vaccinations like Eurican Herpes 205 to ensure ongoing health and preventative care.

What happens if my dog is already infected with herpes virus at the time of vaccination?

Vaccination may not be effective if a dog is already infected with the herpes virus. It's best to complete diagnostics and treatment under veterinary guidance before vaccination.

How can I tell if my dog has been exposed to herpes virus before vaccination?

Signs of herpes virus infection in dogs include coughing, nasal discharge, and lethargy. Consult your vet if you suspect exposure before deciding on vaccinations.